Aries Wealth Management »

Tscan Therapeutics shares owned by Aries Wealth Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Aries Wealth Management from 13F filings

Historical chart of Aries Wealth Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Aries Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Aries Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $79k 10k 7.94
2023-12-31 $58k 10k 5.83
2023-09-30 $35k 10k 3.53

More positions owned by Aries Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Spdr Ser Tr S&p Divid Etf (SDY)
Amazon (AMZN)
Caterpillar (CAT)
Home Depot (HD)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Wisdomtree Tr Us Qtly Div Grt (DGRW)

View all positions for Aries Wealth Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
Adage Capital Partners GP
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
BlackRock
Deer Management
Alphabet
Simplify Asset Management
Geode Capital Management
Millennium Management
Laurion Capital Management
Susquehanna International

View all funds holding Tscan Therapeutics